The aim of this study was to investigate the possible interrelation of serum albumin levels and cognitive function of elderly hip fracture patients. The study involved 331 elderly patients with hip fractures, admitted for rehabilitation. Cognition was assessed by Mini-Mental State Examination (MMSE). MMSE scores less than 24 points were considered suggestive of cognitive impairment. Age, serum albumin levels, and previous stroke emerged as the only statistically significant parameters differing between those with MMSE score less than 24 or higher. After adjusting for confounding variables, the middle and lowest tertiles of serum albumin levels were associated with an increased risk of cognitive impairment (odds ratio 1.97, 95% confidence interval 1.15-3.38, P < .01 vs 3.06 and 1.79-5.23, P < .001, respectively). This study shows that lower serum albumin levels are independently associated with lower MMSE scores in hip fractured elderly patients, supporting the possible role of chronic low-grade inflammation in age-related cognitive decline.
Dziedzic T.Systemic inflammatory markers and risk of dementia. Am J Alzheimers Dis Other Demen. 2006;21: 258-262.
2.
Akiyama H., Barger S., Barmum S., et al. Inflammation and Alzheimer's disease. Neurobiol Aging. 2000;21:383-421.
3.
Eikelenboom P., Hack CE, Kamphorst W., et al. Distribution pattern and functional state of complement proteins and alpha1-antichymotrypsin in cerebral beta/A4 deposits in Alzheimer's disease. Res Immunol.1992;143:617-620.
4.
McGeer EG , McGeer PLThe importance of inflammatory mechanisms in Alzheimer disease. Exp Gerontol. 1998;33:371-378.
5.
Arends YM, Duyckaerts C., Rozemuller JM, Eikeleboom P., Hauw JJMicroglia, amyloid and dementia in Alzheimer disease. A correlative study. Neurobiol Aging. 2000;21:39-47.
6.
Cagnin A., Brooks DJ, Kennedy AM, et al. In-vivo measurement of activated microglia in dementia. Lancet. 2001;358:461-467.
7.
Veerhuis R., Van Breemen MJ, Hoozemans JM, et al. Amyloid beta plaque-associated proteins C1q and SAP enhance the Abeta1-42 peptide-induced cytokine secretion by adult human microglia in vitro. Acta Neuropathol.2003;105:135-144.
8.
Maes OC, Xu S., Yu B., Chertkow HW, Wang E., Schipper HMTranscriptional profiling of Alzheimer blood mononuclear cells by microarray . Neurobiol Aging. 2007;28:1795-1809.
9.
Sala G., Galimberti G., Canevari C., et al. Peripheral cytokine release in Alzheimer patients: correlation with disease severity. Neurobiol Aging. 2003 ;24:909-914.
10.
Strandberg TE, Tilvis RSC-reactive protein, cardiovascular risk factors, and mortality in a prospective study in the elderly. Arterioscler Thromb Vasc Biol. 2000;20:1057-1060.
11.
Kálmán J., Juhász A., Laird G., et al. Serum interleukin-6 levels correlate with the severity of dementia in Down syndrome and in Alzheimer's disease. Acta Neurol Scand.1997;96:236-240.
12.
Dik MG, Jonker C., Hack CE, Smit JH, Comijs HC, Eikelenboom P.Serum inflammatory proteins and cognitive decline in older persons. Neurology. 2005;64: 1371-1377.
13.
Yaffe K., Lindquist K., Penninx BW, et al. Inflammatory markers and cognition in well-functioning African-American and white elders. Neurology. 2003;61:76-80.
14.
Engelhart MJ , Geerlings MI, Meijer J., et al. Inflammatory proteins in plasma and the risk of dementia: the Rotterdam study. Arch Neurol. 2004;61:668-672.
15.
Schmidt R., Schmidt H., Curb JD, Masaki K., White LR, Launer LJEarly inflammation and dementia: a 25-year follow-up of the Honolulu-Asia Aging Study. Ann Neurol. 2002;52:168-174.
16.
Ravaglia G., Forti P., Maioli F., et al. Serum c-reactive protein and cognitive function in healthy elderly Italian community dwellers. J Gerontol A Biol Sci Med Sci.2005;60:1017-1021.
17.
Schram MT, Euser SM, de Craen JM, et al. Systemic markers of inflammation and cognitive decline in old age. J Am Geriatr Soc.2007:55:708-716.
18.
Zuccala G., Marzetti E., Cesari M., et al. Correlates of cognitive impairment among patients with heart failure: results of a multicenter survey. Am J Med. 2005;118:496-502.
19.
Kimura R., Kamino K., Yamamoto M., et al. Albumin gene encoding free fatty acid and beta amyloid transporter is genetically associated with Alzheimer disease. Psychiatry Clin Neurosci.2006;60(suppl 1):S34-S39.
20.
Adunsky A., Levi R., Cecic A., Arad M., Noy S., Barell V.The Sheba model of comprehensive orthogeriatric care for elderly hip fracture patients: a preliminary report. Isr Med Assoc J. 2002;4:259-261.
21.
Inouye SK, van Dyck CH, Alessi CA, Balkin S., Siegal AP, Horwitz RIClarifying confusion: the confusion assessment method. A new method for detection of delirium. Ann Intern Med. 1990;113:941-948.
22.
Folstein M. , Folstein S., McHugh PRMini-Mental State Examination. A practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res. 1975;12:189-198.
23.
Tombaugh TN , McIntyre NJThe mini-mental state examination: a comprehensive review. J Am Geriatr Soc. 1992;40:922-935.
24.
Gruber-Baldini AL, Zimmerman S., Morrison RS, et al. Cognitive impairment in hip fracture patients: timing of detection and longitudinal follow-up. J Am Geriatr Soc. 2003;51:1227-1236.
25.
BelooseskyY. , Hendel D., Weiss A., et al. Cytokines and C-reactive protein production in hip-fracture operated elderly patients. J Gerontol A Biol Sci Med Sci.2007;62:420-426.
26.
Katz IR, Beaston-Wimmer P., Parmelee P., Friedman E., Lawton MPFailure to thrive in the elderly: exploration of the concept and delineation of psychiatric components. J Geriatr Psychiatry Neurol. 1993;6:161-169.
27.
Mago R., Bilker W., Ten Have T., et al. Clinical laboratory measures in relation to depression, disability, and cognitive impairment in elderly patients. Am J Geriatr Psychiatry. 2000;8:327-332.
